Introduction
============

Cardiovascular disease remains a leading cause of morbidity and mortality in both industrialized and developing countries, despite effective treatments that target established cardiovascular risk factors. However, the most important predictor of cardiovascular disease, age itself, evades specific interventions. Aging leads to a multitude of changes in the vasculature.^[@b1]--[@b3]^ Morphological changes include dilation of the central aorta^[@b3]^ and increased arterial wall thickness, even in the absence of atherosclerotic disease,^[@b4]^ mainly as a result of intimal thickening.^[@b5]^ Moreover, aging is associated with increased collagen deposition and elastin fracture/fragmentation in the extracellular matrix (ECM).^[@b6]^ These alterations lead to an increase in vascular stiffness,^[@b7]^ which is manifest as central pressure augmentation,^[@b8]^ systolic hypertension, increased pulse pressure,^[@b9]^ and a higher central blood pressure (BP) for any given peripheral (eg, brachial) BP.^[@b10]^ Assessments of arterial stiffness, such as pulse wave velocity (PWV), indices of wave reflection, and augmentation of central aortic BP, are increasingly being recognized as critical indicators to predict cardiovascular morbidity and mortality in the clinical setting^[@b11]^ and are associated with other risk factors, such as renal failure,^[@b12]^ stroke,^[@b13]^ coronary artery disease,^[@b14]^ impaired glucose metabolism,^[@b15]^ chronic inflammatory disease,^[@b16]^ smoking, and caffeine use.^[@b17]^ PWV, the speed at which the arterial pulse waveform propagates along the vascular tree, has gained particular interest in recent years and is increasingly utilized as a marker of cardiovascular disease and morbidity.^[@b18]^ PWV is directly related to stiffness, as defined by the Moens‐Korteweg equation: PWV=√(*Eh*/2*pR*), where *E* is Young\'s modulus of the arterial wall, *h* is wall thickness, *R* is arterial radius, and *p* is blood density. Aging is associated with increased PWV.^[@b19]--[@b20]^ At the cellular level, endothelial dysfunction and alterations in vascular smooth muscle function are well documented in the aging vasculature.^[@b21]--[@b22]^ However, the molecular mechanisms underlying these dynamic (eg, cell function) and structural (eg, elastin/collagen content) changes in age‐related vascular stiffness remain poorly understood. Therefore, targeted therapy remains elusive. Aging is accompanied by an altered redox milieu and decreased nitric oxide (NO) bioavailability, which accentuates vascular injury and/or impairs vascular repair. One of the enzymes intimately regulated by NO, and therefore affected by decreased NO levels with aging, is tissue transglutaminase (TG2).^[@b23]^ TG2 is expressed in the vascular endothelium, smooth muscle cells, and fibroblasts.^[@b24]^ TG2 is secreted to the ECM, where it catalyzes cross‐linking of ECM proteins, such as collagen, in a Ca^2+^‐dependent manner.^[@b25]^ We have recently demonstrated, in young rat aorta, that TG2 secretion and cross‐linking function are inhibited by S‐nitrosylation, a redox‐sensitive post‐translational modification of cysteine residues by NO.^[@b23]^ Loss of NO bioavailability in old rats leads to decreased TG2 S‐nitrosylation, increased TG2 in the vascular matrix, and increased TG2 cross‐linking function. Inhibition of TG2 in 15‐month‐old rats attenuated the age‐associated increase in PWV.^[@b23],[@b26]--[@b27]^ The role of endothelial nitric oxide synthase (eNOS)‐dependent NO in regulating TG2 function is also evident as TG2 secretion and cross‐linking activity are higher in eNOS−/− mice, compared to wild type (WT), which further coincides with increased vascular stiffness in eNOS−/− mice.^[@b28]^ Therefore, it is of interest to further consider the role of TG2 in vascular stiffness to determine its therapeutic potential.

In the absence of well‐established therapeutic targets, lifestyle modifications, such as diet and moderate exercise, constitute the mainstay of therapy. Exercise, in particular, has been shown to broadly influence age‐related vascular stiffness by decreasing BP and improving endothelial function (and therefore NO bioavailability), among others.^[@b29]--[@b33]^ In this study, we tested the hypothesis that exercise‐mediated upregulation of NO decreases TG2 activity and thereby improves vascular stiffness in the commonly used Fischer 344 rat model of aging.^[@b34]^

Methods
=======

Animals and Study Design
------------------------

Male Fischer 344 rats were used in compliance with federal, state, local, and National Research Council guidelines. TG2−/− and WT mice were bred in‐house. Animals were fed and watered *ad libitum*. All surgical procedures and experimental protocols were approved by the Institutional Animal Care and Use Committee, which is accredited by the American Association for Accreditation in Laboratory Animal Care. First, the relationship between PWV and BP in Fischer 344 rats at different age groups (n=49) was evaluated. Next, the influence of 4 weeks of moderate exercise in 20‐month‐old animals (n=4), compared to age‐matched sedentary controls (n=10) and a young control group (6 months old; n=10) was examined. Finally, the effect of 14 weeks of moderate exercise was studied in middle‐aged rats (11 months old; n=8, exercise group) and compared to an age‐matched sedentary control group (old control group; n=7) and a young control group (6 months old; young control group, n=13).

Exercise Regimen
----------------

Animals in the exercise group were exercised daily on a rodent treadmill (Columbus Instruments, Columbus, OH) for 40 min/day at approximately 50% of maximal exercise tolerance.^[@b35]^ Rats were acclimatized to the treadmill for 1 week by walking daily for 40 minutes starting at a speed of 5 m/min with increments of 1 m/min per day. After this period of acclimatization, rats were exercised daily for either 4 weeks (20 months old; see [Figure 1](#fig01){ref-type="fig"}) or for 14 weeks (11 months old; see Figures [2 through 6](#fig06){ref-type="fig"}) at 12 m/min at an incline of 5° for the period of the study.

![Effect of age and exercise in old rats. Old rats (20 months old) and young rats (6 months old) were examined. A, Aging is associated with increased vascular stiffness independent of exercise; B, TG activity increases with age in sedentary, but not in exercised, rats; and C, TG2 abundance remained unchanged. MAP indicates mean arterial pressure; PWV, pulse wave velocity; TG, transglutaminase.](jah3-3-e000599-g1){#fig01}

![Nitric oxide signaling in aging and exercise. A, Old animals (old; 14 months old) have significantly reduced peNOS/eNOS and pVASP/VASP ratios, compared to young animals (young controls; 6 months old). A 14‐week period of exercise (old ex; 14 months old) partially restores these ratios toward the young phenotype. B, Bar graphs of densitometry analysis of peNOS/eNOS (n=12 in each group; *P*=0.0220 by 1‐way ANOVA; \**P*\<0.05 young vs old and \**P*\<0.05 old vs old ex by Tukey\'s post‐hoc test). C, Bar graphs of densitometry analysis of pVASP/VASP (n=12 in each group; *P*=0.0127 by 1‐way ANOVA; \**P*\<0.05 young vs old and \**P*\<0.05 old vs old ex by Tukey\'s post‐hoc test). VASP indicates vasodilator‐stimulated phosphoprotein, eNOS indicates endothelial nitric oxide synthase, GAPDH indicates glyceraldehyde 3‐phosphage dehydrogenase.](jah3-3-e000599-g2){#fig02}

![Exercise attenuates age‐associated changes in TG activity and S‐nitrosylation in old animals. A, TG activity increases and TG2‐nitrosylation decreases with age in sedentary rats, but not in rats subjected to 14 weeks of moderate aerobic exercise; TG2 abundance is not affected by age and exercise; bar graphs of densitometry analysis are shown on the right (n=8 in each group; TG2SNO, *P*=0.017 by 1‐way ANOVA; \**P*\<0.05 young vs old and old vs old ex by Tukey\'s post‐hoc test; TG2 activity, *P*=0.0005 by 1‐way ANOVA; \**P*\<0.05 young vs old and old vs old ex by Tukey\'s post‐hoc test). B, TG cross‐links (examined by digestion of vascular matrix followed by dot blotting with cross‐links antibody 81D4) increase with age independent of exercise in the rat aorta (n=4 in each group; *P*=0.01); WT and TG2−/− mouse aorta were used to confirm specificity of the method (n=4 in each group); (C), Immunohistochemical analysis of TG2 abundance (left) and TG‐specific cross‐links (right); IHC scores are represented in the bar graphs on the right (n=4 in each group); (D) Negative controls for IHC lacking TG2 primary antibody (left) or 81D4 antibody for cross‐links (right). IHC indicates immunohistochemistry; TG, transglutaminase; TG2‐SNO, S‐nitrosylated TG2; WT, wild type.](jah3-3-e000599-g3){#fig03}

![TGases in the rat vasculature. A, TG4 is expressed in the rat aorta and its abundance decreases with age (n=3 in each group; rat prostate used as positive control; actin used as loading control; bar graph of densitometry is shown on the right; *P*=0.01 young vs old by Student *t* test); B, TG1 expression was not detected in the rat aorta (n=3 in each group; skin sample used as positive control; actin used as loading control); C, TG2 inhibitor L682.777 (10 μmol/L) markedly inhibits FITC cadaverine incorporation in the ECM of the rat aorta (n=3 in each group); D, L682.777 (10 μmol/L) and cystamine (200 μmol/L) inhibit \>75% of TG activity in young and old rat aorta; bar graph of densitometry analysis shown on the right (n=4 in each group; \**P*=0.0004 for age effects; ^\#^*P*\<0.0001 for drug effects by 2‐way ANOVA with Bonferroni multiple comparisons). BPA indicates 5‐(biotinamido)pentylamine; ECM, extracellular matrix; FITC, fluorescein isothiocyanate; TG, transglutaminase.](jah3-3-e000599-g4){#fig04}

![Elasticity and composition of the vascular matrix during aging and exercise. A, Aortic samples from old sedentary animals (blue) are significantly stiffer than young control aortas (red), as compared by tensile testing. Fourteen weeks of moderate exercise leads to a small, but statistically significant, shift in the tensile properties toward the young phenotype (purple). Solid lines represent the average values (n=7); dotted lines represent SE (*P*=0.001 by 1‐way ANOVA; \**P*\<0.05 old vs young; ^\#^*P*\<0.05 old vs old exercise by Bonferroni post‐hoc analysis); B, IHC analysis of collagen (Masson Trichrome) and elastin (VVG) in the rat aorta; C, Hydroxyproline assay was used to determine collagen crosslinks; and D, MMP activity was measured in the 3 groups examined in this study (n=4 in each group; \**P*\<0.05). IHC indicates immunohistochemistry; MMP, matrix metalloprotease; VVG, Verhoeff‐Van Gieson stain.](jah3-3-e000599-g5){#fig05}

![PWV‐MAP profiles change with age, but not with exercise. A, PWV increases exponentially with rising MAP. This increase is exaggerated with aging; Inset: PWV measured at the initial blood pressure increases with age in the Fischer 344 rat model; B, PWV‐MAP correlation in the exercise cohort is not altered by exercise in old animals. BP indicates blood pressure; MAP, mean arterial pressure; PWV, pulse wave velocity.](jah3-3-e000599-g6){#fig06}

Invasive PWV Measurements
-------------------------

All animals were anesthetized in a closed chamber with isoflurane. After supine positioning on a temperature‐controlled surface (Cole‐Parmer, Vernon Hills, IL) with fore‐ and hindpaws taped, anesthesia was maintained with 1.5% isoflurane (in 100% O~2~) by mask. Body temperature was maintained at 37°C and a 3‐electrode ECG was continuously recorded (ADInstruments, Colorado Springs, CO). Additionally, local anesthesia was provided with 2% lidocaine. A cervical midline excision was performed and the left carotid artery was exposed using a blunt dissection technique. A 1.6F dual pressure catheter (Scisence Inc, London, Ontario, Canada) was inserted into the thoracic aorta with the distal tip located just above the diaphragm and the proximal tip below the aortic arch to continuously measure BP and pulse transit time (LabChart 6; ADInstruments). In order to study the relationship between PWV and BP over a wide range of BPs, a left jugular venous catheter was placed and a phenyleprhine infusion was titrated to a systolic BP of 200 mm Hg. The infusion was then stopped, allowing the BP to return to baseline. Once baseline pressure was restored, sodium nitroprusside was infused to lower the systolic BP to 50 mm Hg, at which point the infusion was stopped, again allowing the BP to return to baseline. PWV was calculated after each infusion was discontinued (ie, during the period in which the BP returned to baseline). PWV was calculated using a macro written for LabChart 6 (ADInstruments). Pulse transit time was obtained from the pulse foot‐to‐foot delay, where a fiducial point was determined using the time of the peak of the second time differential of the pressure pulse. Pulse transit time for each pulse was obtained by gating using the ECG R wave. PWV was then calculated as distance between the 2 transducers (2 cm) divided by transit time (0.02 m/transit time \[sec\]). The PWV value obtained was transferred to a spreadsheet and grouped with a precision of 10 mm Hg. Data were graphed and analyzed using Prism 5 (GraphPad Software Inc., La Jolla, CA). Curve fitting was performed using sigmoidal dose response (variable slope method) with an ordinal *x*‐axis.

Tensile Testing
---------------

Rat aorta was harvested, cut into 2‐mm rings, and mounted onto the pins of an electromechanical puller (DMT560; Danish Myo Technology A/S, Aarhus, Denmark). After calibration and alignment, the pins were slowly moved apart using an electromotor at a rate of 50 μm/sec to apply radial stress on the specimen until breakage. Displacement and force were recorded continuously. A 1‐mm segment proximal to the ring was imaged at ×10 magnification along with a graticule. Vessel inner (D~i~) and outer diameters (D~o~) were measured at 4 different locations with ImageJ software (National Institutes of Health \[NIH\], Bethesda, MD). Average D~i~ and D~o~ values were used to calculate sample thickness. Engineering stress (S) was calculated by normalizing force (F) to the initial stress‐free area of the specimen (S=F/2t×l; where t=thickness and l=length of the sample). Engineering strain (λ) was calculated as the ratio of displacement to the initial stress‐free diameter. The stress‐strain relationship was represented by the equation S=α exp (βλ), where α and β are constants. α and β were determined by nonlinear regression for each sample and used to generate [Figure 3](#fig03){ref-type="fig"} by treating the *x*‐axis as a continuous variable.

Western Blotting
----------------

Samples were homogenized in 1× radioimmunoprecipitation assay (RIPA) buffer containing protease and phosphatase inhibitors, centrifuged at 13 500*g* for 5 minutes at 4°C, and total protein concentration in the supernatants was determined (Bio‐Rad Protein Assay Reagent; Bio‐Rad, Hercules, CA). Duplicate gels containing homogenized samples (10 to 25 μg) were resolved by SDS‐PAGE and electrotransferred to a nitrocellulose membrane. After blocking (3% nonfat dry milk, 1 hour at room temperature), the membranes were incubated with primary antibody for 1 hour at room temperature, rinsed, and incubated with horseradish peroxidase (HRP)‐conjugated secondary antibody (Bio‐Rad). The first membrane was used to determine phosphorylated vasodilator‐stimulated phosphoprotein (pVASP) and phosphorylated eNOS (peNOS) and was subsequently stripped with Restore Plus stripping buffer (Pierce, Rockford, IL) and reused to determine total VASP and eNOS abundance. The second membrane was used to determine TG2 and GAPDH abundance. Rabbit pVASP Ser239 and mouse VASP were from Cell Signaling (1:1000; Danvers, MA), rabbit peNOS and mouse eNOS were from BD Bioscience (1:1000; San Jose, CA), mouse GAPDH was from Novus Biologicals (1:1000; Littleton, CO), rabbit tissue transglutaminase was from NeoMarkers (1:1000; Fremont, CA), transglutaminase 1 was from Abcam (1:1000; Cambridge, MA), and transglutaminase 4 was from Santa Cruz Biotechnology (1:1000; Santa Cruz, CA). Blots were developed using enhanced chemiluminescence and quantitated using ImageJ software (NIH). Four biological replicates were examined from each group on the same gel (Bio‐Rad Criterion 12+2 well gel; Bio‐Rad). The average density of bands from the young cohort was used to normalize the data. Homogenate of rat prostate sample was used as a positive control for TG4 and human skin sample was used as a positive control for TG1 expression.

TG Activity Assay
-----------------

A dot blot assay was used to determine TG activity as previously described.^[@b23]^ Intact tissues were incubated with 0.1 mmol/L of 5‐(biotinamido)pentylamine (BPA) and 1 mmol/L Ca^2+^ at 37°C for 4 hours in culture media (phenol red‐free DMEM supplemented with 2% FBS and penicillin/streptomycin) and then rinsed to free it of unreacted BPA using PBS. Samples were then homogenized in 1× RIPA buffer containing protease and phosphatase inhibitors. Proteins (0.5 to 1 μg) were loaded onto nitrocellulose membrane (BioDot Dot Bolt apparatus; Bio‐Rad). The membrane was rinsed and blocked in 3% BSA overnight and probed with HRP‐conjugated streptavidin (1:10 000 dilution in 3% BSA; Amersham Bioscience, Foster City, CA) to determine BPA incorporation. Blots were stripped using Restore Plus stripping buffer (Pierce) and reprobed with GAPDH to determine protein loading. BPA incorporation and GAPDH levels were determined by densitometry analysis using ImageJ software. For each sample, activity was calculated as the ratio of BPA/GAPDH. The nonspecific TG inhibitor, cystamine, was from Sigma‐Aldrich (St. Louis, MO), and the nonpeptidyl active site‐directed specific TG2/Factor XIII inhibitor, L682.777, was from Zedira (Darmstadt, Germany).

S‐Nitrosylation Assay
---------------------

TG2 S‐nitrosylation was determined using the biotin switch assay in tissue homogenates.^[@b23],[@b26]^

Measurement of TG Cross‐links
-----------------------------

The 81D4 antibody (Covalab, Villeurbanne, France) was used to detect Nε‐(γ‐glutamyl)‐lysine bonds in the aorta using an approach published by Thomas et al.,^[@b36]^ with some modifications. Aortic segments were crushed using a mortar and pestle and homogenized using RIPA buffer. Samples were centrifuged at 13 500*g* for 5 minutes in preweighed microcentrifuge tubes and the supernatant was removed. The resulting pellet was washed 2× in RIPA buffer and the tubes weighed again to obtain wet pellet weight. Pellets were then resuspended in solution of collagenase (50 units/mL each of collagenase 1, 2, 3, and 4; Calbiochem, San Diego, CA) and elastase (0.5 units/mL) and incubated for 3 days at 37°C. Samples were centrifuged at 13 500*g* for 5 minutes, the supernatant removed, and the tubes weighed again to obtain undigested pellet weight. An equivalent amount of digested pellet from each sample was loaded on a nitrocellulose membrane using the Bio‐Rad dot blot apparatus. Nε‐(γ‐glutamyl)‐lysine bonds were examined using the 81D4 antibody (1:250 in 3% nonfat dry milk, 4°C overnight; Covalab). Aorta from 12‐week‐old WT and TG2−/− mice were used to validate the dot blot approach to detect cross‐links.

IHC Staining for TG2 and TG‐Generated Cross‐links
-------------------------------------------------

Rat aortic tissue segments were fixed for 24 hours in 10% neutral formaldehyde. The tissue segments were embedded in paraffin, and 5‐μm transverse sections were cut using a Reichert‐Jung 2030 biocut rotary microtome. The tissue sections were mounted on positively charged aminopropyl‐triethoxysilane--coated glass slides and deparaffinized using successive washes with xylene/ethanol/water. Briefly, after deparaffinization and rehydration, slides were incubated with 3% H~2~O~2~ to block endogenous peroxidase activity. Antigen retrieval was performed using 0.01 mol/L of sodium citrate buffer in a microwave oven for 10 minutes. Before immunohistochemical (IHC) staining, the sections were blocked with 10% goat serum for 30 minutes. To detect TG2, the sections were incubated with 5 μg/mL of anti‐TG2 monoclonal antibody (mAb) CUB7402 (NeoMarkers) for 60 minutes at room temperature. To localize the TG2‐generated cross‐links, the sections were incubated with 10 μg/mL of mAb 81D4 specific for Nε‐(γ‐glutamyl)‐lysine isodipeptide cross‐links (Covalab) for 18 hours at 4°C. The slides were washed and incubated with secondary goat anti‐mouse immunoglobulin (Ig)G (for TG2) or anti‐mouse IgM (for cross‐links) conjugated with HRP for 30 minutes at room temperature. HRP activity was developed with 3,3′‐diaminobenzidine chromagenic substrate (Vector Laboratories, Burlingame, CA) for 5 minutes per the manufacturer\'s instructions. The sections were counterstained with hematoxylin to visualize nuclei before mounting with coverslips.

IHC Scoring
-----------

Digital images were taken using an Olympus DP20 camera system (Olympus, Tokyo, Japan) and white balanced using Photoshop CS2 (Adobe). An open‐source image analysis software program (FrIDA) was used to score individual images.^[@b37]^ Regions of interest (ROIs) were separately created for the media and adventitia of each vessel. Brown pixels were identified using a color‐picking algorithm that captured a user‐defined region of hue, saturation, and luminosity, and the percent of brown pixels to total pixels within each ROI was determined. For TG2, the media ROI was evaluated and for the cross‐links the adventitia ROI was used.

Statistical Analysis
--------------------

All data are presented as mean±SEM. One‐way ANOVA, followed by a Tukey or Boneferroni post‐hoc analysis, was used, as indicated, for group comparisons. Two‐way ANOVA with Bonferroni multiple comparisons test was used for multiple comparisons. A value of *P*\<0.05 was considered significant.

Results
=======

Effect of Exercise on Vascular Stiffness in Old Rats
----------------------------------------------------

We initially tested the influence of aerobic exercise for 4 weeks on TG2 abundance, cross‐linking activity, and PWV in 20‐month‐old rats ([Figure 1](#fig01){ref-type="fig"}A). There was a significant increase in TG2 activity in old animals, as compared to young animals ([Figure 1](#fig01){ref-type="fig"}B), whereas TG2 abundance remained unchanged ([Figure 1](#fig01){ref-type="fig"}C). TG activity in the exercise cohort was comparable to young controls. However, PWV increased significantly in old animals, as compared to young controls, despite a brief period of aerobic exercise (4 weeks). Given this result, we hypothesized that initiating exercise at a younger age and extending the regimen for a longer period of time might prevent the NO‐dependent cross‐linking process. Therefore, the effect of 14 weeks of moderate‐intensity exercise in an 11‐month‐old cohort of rats (hereafter referred to as the "old" group) was examined in this study. Sedentary age‐matched animals and 6‐month‐old (young) rats were used as controls. [Table](#tbl01){ref-type="table"} demonstrates whole body weight, baseline BP, and heart rate in the 3 groups examined in this study.

###### 

Characteristics of Animals Used in this Study

                         Young Animals (6 Months Old; n=13)   Sedentary Old (14 Months Old; n=7)   Old Exercise (14 Months Old; n=8)
  ---------------------- ------------------------------------ ------------------------------------ -----------------------------------
  Whole body weight, g   409±17                               473±30                               431±8
  Mean BP, mm Hg         101±5.76                             96.7±9.93                            100±8.04
  Heart rate, bpm        293±35                               290±22                               270±30

BP indicates blood pressure.

NO Signaling During Aging and Exercise
--------------------------------------

Phosphorylation of eNOS at Ser1177 in response to various stimuli is known to activate NO synthesis. Moreover, VASP is phosphorylated at Ser239 by the cGMP‐dependent kinase, PKG. Thus, peNOS Ser1177 was determined as a measure of active eNOS in the rat aorta, and pVASP Ser239 levels were used to examine NO/cGMP signaling.^[@b38]--[@b39]^ Both peNOS/NOS and pVASP/VASP ratios declined significantly in the sedentary old rats ([Figure 2](#fig02){ref-type="fig"}), compared to young. These ratios were similar to the young cohort in the old exercise group and significantly higher compared to the old sedentary animals. GAPDH was used as the loading control.

TG2 Function During Aging and Exercise
--------------------------------------

The effect of age and exercise on TG cross‐linking activity was examined. There was significant increase in TG activity (measured by BPA incorporation) in old sedentary animals, but not in the old exercise group, relative to the young controls ([Figure 3](#fig03){ref-type="fig"}A). TG2 S‐nitrosylation diminished with age in the sedentary, but not in the exercise, group ([Figure 3](#fig03){ref-type="fig"}A), compared to young controls. TG2 abundance remained unchanged in the 3 groups as determined by western blotting ([Figure 3](#fig03){ref-type="fig"}A). TG cross‐links (as examined by digesting the vascular matrix followed by a dot blot using the 81D4 antibody) increased significantly with age and were not altered by exercise ([Figure 3](#fig03){ref-type="fig"}B). The specificity of the method was confirmed by examining TG cross‐links in digests of WT mouse aorta with TG2−/− mouse aorta as negative control ([Figure 3](#fig03){ref-type="fig"}B, right panel). TG2 abundance and TG cross‐links were also determined by IHC ([Figure 3](#fig03){ref-type="fig"}C; negative controls are shown in [Figure 3](#fig03){ref-type="fig"}D). There was a modest increase in TG cross‐links in both the sedentary and exercise groups, compared to young, but the data did not reach statistical significance. In addition to TG2, TG4 was detected in the rat aorta (prostate sample used as positive control; [Figure 4](#fig04){ref-type="fig"}A) and its abundance decreased with age, whereas TG1 was not detected (skin sample used as positive control; [Figure 4](#fig04){ref-type="fig"}B). FITC cadaverine was incorporated in the ECM in the vasculature ([Figure 4](#fig04){ref-type="fig"}C) in a TG2‐dependent manner, and L682.777 (10 μmol/L), a specific inhibitor to TG2 and Factor XIII,^[@b40]^ inhibited over 75% of TG activity in both young and old rat aorta ([Figure 4](#fig04){ref-type="fig"}C and [4](#fig04){ref-type="fig"}D). The nonspecific TG inhibitor, cystamine (200 μmol/L), yielded similar results ([Figure 4](#fig04){ref-type="fig"}D).

Mechanical Properties of Aorta During Aging and Exercise
--------------------------------------------------------

Next, ex vivo tensile tests were performed using an electromechanical puller to evaluate the mechanical properties of the thoracic aorta. Aortic samples from young rats were more elastic, compared to old rats (both sedentary and exercise groups), as demonstrated by an up‐ and leftward shift of the stress‐strain curve ([Figure 5](#fig05){ref-type="fig"}A). The aortas from the exercise group were statistically significantly more elastic than the sedentary group, but demonstrated tensile properties that were more similar to the sedentary old rats than to the young rats. Collagen content (IHC, [Figure 5](#fig05){ref-type="fig"}B and hydroxyproline assay, [Figure 5](#fig05){ref-type="fig"}C) trended toward an increase in the sedentary old rats, but did not reach statistical significance. Elastin content ([Figure 5](#fig05){ref-type="fig"}B) was similar in all 3 groups. MMP activity was significantly higher in the sedentary old rats, compared to young controls ([Figure 5](#fig05){ref-type="fig"}D).

Influence of Aging and Exercise on Vascular Stiffness
-----------------------------------------------------

PWV measurements were used to assess in vivo vascular stiffness. Given the importance of pressure dependence of PWV, an invasive dual pressure catheter was used to determine pulse transit time and generate PWV‐MAP relationships over a wide range of blood pressures. First, the effect of age on the PWV‐MAP correlation was examined. PWV was dependent on BP and increased with rising MAP ([Figure 6](#fig06){ref-type="fig"}A). There was a significantly greater increase in PWV with MAP in the old phenotype, compared to young ([Figure 6](#fig06){ref-type="fig"}A). PWV measured at the initial pressure increased rapidly with age until 6 months and at a slower rate thereafter ([Figure 6](#fig06){ref-type="fig"}A, inset). The aerobic exercise regimen used in this study did not alter the PWV‐MAP curve in the exercise cohort, compared to age‐matched sedentary controls ([Figure 6](#fig06){ref-type="fig"}B).

Discussion
==========

The benefits of regular exercise in preventing or reducing the deleterious effects of various cardiovascular pathologies, such as hypertension, coronary artery disease, atherosclerosis, and aging are well known.^[@b41]^ Seals et al.^[@b29]^ have shown that the increase in carotid artery stiffness that occurs with aging is largely absent in humans who are either habitually physically active or exercise trained. The mechanisms by which exercise exerts its beneficial effects are complex, but, in part, involve improved endothelial function.^[@b42]^ Regular exercise results in an increase in blood flow, thus exerting higher shear stress on endothelial cells. This, in turn, results in increased Akt‐dependent eNOS phosphorylation, and thus increased NO production, which contributes to the beneficial effects of exercise on vascular function.^[@b43]^ In addition to increased vasodilation through cGMP, NO can indirectly regulate vascular properties through protein S‐nitrosylation. We have previously shown that TG2 plays a role in vascular stiffening associated with aging, and that eNOS‐dependent NO regulates TG2 function.^[@b23],[@b26]--[@b28]^ In this study, the effect of exercise mediated improvements in NO bioavailability on TG2 function, and consequently, the mechanical properties of the arterial vasculature were examined. Endothelial function was impaired with age (reduced peNOS and pVASP levels) in the sedentary group and was largely preserved in the exercise cohort, which is in agreement with previous studies.^[@b43]^ Moreover, TG2 S‐nitrosylation was maintained and its cross‐linking activity was suppressed in the exercise cohort, but not in the sedentary rats, compared to young controls. Thus, in this study, we demonstrate that increased NO resulting from a physiologic stimulus (ie, exercise) can alter protein function through S‐nitrosylation.

PWV, as an indicator of vascular stiffness, has been shown to correlate with morbidity and mortality in the clinical setting.^[@b18]^ Traditionally, PWV is measured noninvasively as a single‐point measurement. However, wall stiffness depends on the distending pressure resulting from the elastic nature of arteries, which, in turn, is related to the composition and structure of the wall and its load‐bearing components (mainly elastin and collagen) in the ECM. Hence, changes in PWV must be adjusted for arterial pressure in order to accurately reflect changes in arterial stiffness.^[@b44]^ We therefore measured PWV invasively over a wide range of blood pressures. As predicted, PWV varied greatly over the range of MAPs examined in this study, almost doubling at higher MAPs, compared to resting BP ([Figure 6](#fig06){ref-type="fig"}). This is in agreement with previous work by Ng et al., who have demonstrated the interaction of PWV and BP in a model of chronic kidney disease.^[@b45]^ As shown in this study, aging resulted in effects similar to those observed in vascular calcification. Though exercise led to increased TG2 S‐nitrosylation and decreased TG2 activity along with improved vascular elasticity ex vivo, this did not translate to improvement in aortic stiffness determined by PWV‐MAP measurements. This dichotomy might be a result of alterations to the ECM preceding the initiation of the exercise regimen in this study at 11 months of age. It is well established that cross‐linked collagen has a relatively long half‐life in vivo. Thus, though exercise may suppress further alterations to the vascular matrix, it cannot reverse changes that have accumulated between 6 and 11 months of age, and therefore may not significantly impact arterial stiffness and thus the PWV‐MAP curve. Together, these data suggest that the lower single‐point PWV observed with exercise in other rat studies may be the result of decreased MAP and/or lower resting heart rate and not the result of altered intrinsic stiffness of the vessel wall. Thus, in this study, the benefits of exercise to the vasculature included improved NO bioavailability and reduced oxidative stress, as well as reduced TG2 cross‐linking function, but not a direct effect on vascular stiffness.

Limitations
-----------

There is ongoing debate on the impact of exercise intensity on improving cardiovascular status.^[@b35],[@b46]--[@b47]^ We chose a model of continuous moderate exercise to resemble the regimen commonly practiced and recommended for adults to improve cardiovascular function.^[@b47]^ However, high‐intensity aerobic interval training might be more efficient at improving vascular function.^[@b35],[@b46]^ The effect of high‐intensity aerobic exercise on the PWV‐MAP curves remains to be elucidated and is the focus of ongoing studies in our laboratory. Furthermore, the possibility of a longer period of exercise maintaining the PWV‐MAP relationship similar to the young phenotype cannot be excluded. Also, the effects of aging and exercise may be gender specific. In a recent study on a human cohort of seniors, male participants in an exercise group did not demonstrate improvements in arterial stiffness, whereas female participants did.^[@b48]^ The effect of exercise on female animals was not examined in this study, and this difference remains the focus of ongoing experiments. Whereas the well‐established, commonly used Fischer 344 rat model of aging was examined in this study, strain differences have been described for a variety of vascular processes and the applicability of animal studies to humans is always of concern. Indeed, Fischer 344 rats have an early rapid increase in PWV (3 to 6 months; corresponding to ≈18‐year‐old human adults), with a smaller rate of increase in PWV thereafter. However, PWV increases more rapidly in middle‐aged and elderly humans,^[@b19]--[@b20]^ compared to young adults. It would therefore be of interest to investigate the effect of exercise in younger rats (ie, initiate the exercise regimen at 3 months for a total of 12 weeks or longer). Furthermore, though there is a clear relationship between eNOS‐dependent NO production and TG2, as demonstrated previously,^[@b23],[@b27]--[@b28],[@b26]^ and it has been well established that exercise influences eNOS‐dependent NO,^[@b42],[@b49]--[@b50]^ we do not provide a direct mechanistic relationship, but rather an association between exercise‐mediated improvement in eNOS function and TG2 activity, in this study.

The arterial pressure at the time of surgery was recorded in anesthetized rats; BP in conscious animals was not measured in this study. Also, the vasoactive drugs, phenylephrine and sodium nitroprusside, were used to vary BP in the invasive PWV‐MAP measurements. It is assumed that the main site of action of these drugs is in the resistance arteries, although it is possible that they may also affect the tone of the smooth muscle cells in the aortic wall. By nonpharmacological manipulation of arterial pressure using maneuvers that affect venous return, we have verified that changes in PWV during the drug infusions are the result of pressure changes associated with altered resistance (Alberto Avolio and Mark Butlin, unpublished observations). Furthermore, because phenylephrine and sodium nitroprusside were administered equally to all treatment groups, any possible confounding effects, although minor, would apply equally to all groups, hence not affecting comparisons across groups.

In this study, while a brief period of moderate aerobic exercise did not prevent age‐associated increase PWV, it successfully maintained NO signaling in aging rats.
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